Solid Biosciences (SLDB) Retained Earnings (2017 - 2024)
Historic Retained Earnings for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to -$740.9 million.
- Solid Biosciences' Retained Earnings fell 1605.27% to -$740.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$740.9 million, marking a year-over-year decrease of 1605.27%. This contributed to the annual value of -$658.8 million for FY2023, which is 1706.21% down from last year.
- Solid Biosciences' Retained Earnings amounted to -$740.9 million in Q3 2024, which was down 1605.27% from -$708.1 million recorded in Q2 2024.
- Solid Biosciences' 5-year Retained Earnings high stood at -$343.0 million for Q1 2020, and its period low was -$740.9 million during Q3 2024.
- For the 5-year period, Solid Biosciences' Retained Earnings averaged around -$529.9 million, with its median value being -$527.2 million (2022).
- In the last 5 years, Solid Biosciences' Retained Earnings crashed by 5000.7% in 2020 and then tumbled by 1468.83% in 2024.
- Quarter analysis of 5 years shows Solid Biosciences' Retained Earnings stood at -$404.6 million in 2020, then decreased by 17.84% to -$476.8 million in 2021, then decreased by 18.03% to -$562.7 million in 2022, then fell by 17.06% to -$658.8 million in 2023, then dropped by 12.47% to -$740.9 million in 2024.
- Its Retained Earnings was -$740.9 million in Q3 2024, compared to -$708.1 million in Q2 2024 and -$683.1 million in Q1 2024.